Characteristics of the study group
. | HIV-infected patients . | AIDS patients . | Controls . |
|---|---|---|---|
| No. subjects | 8 | 7 | 13 |
| Median age, y (range) | 38 (32-52) | 37 (34-56) | 37 (29-61) |
| No. men/no. women | 6/2 | 5/2 | 9/4 |
| No. CD4+ T cells, × 106/L (range) | 280 (95-430) | 45 (10-110) | 760 (540-980) |
| No. CD8+ T cells, × 106/L (range) | 710 (410-1170) | 280 (110-430) | 400 (210-550) |
| TNF-α, pg/mL (range) | 25 (12-37) | 65 (40-98) | 8 (0-12) |
| HIV RNA copies/mL plasma, × 103 (range) | 44.2 (22.9-108.6) | 510.9 (210.0-1200.0) | NA |
. | HIV-infected patients . | AIDS patients . | Controls . |
|---|---|---|---|
| No. subjects | 8 | 7 | 13 |
| Median age, y (range) | 38 (32-52) | 37 (34-56) | 37 (29-61) |
| No. men/no. women | 6/2 | 5/2 | 9/4 |
| No. CD4+ T cells, × 106/L (range) | 280 (95-430) | 45 (10-110) | 760 (540-980) |
| No. CD8+ T cells, × 106/L (range) | 710 (410-1170) | 280 (110-430) | 400 (210-550) |
| TNF-α, pg/mL (range) | 25 (12-37) | 65 (40-98) | 8 (0-12) |
| HIV RNA copies/mL plasma, × 103 (range) | 44.2 (22.9-108.6) | 510.9 (210.0-1200.0) | NA |
Data are given as medians and as 25th to 75th percentiles if not otherwise stated. T-cell subset counts were analyzed in peripheral blood and TNF-α levels in plasma. NA indicates not applicable.